U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07787169) titled 'A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease' on Aug. 24.
Brief Summary: The purpose of this Master Protocol is to support multiple studies looking at safety and tolerability of different drugs in healthy participants and participants with Alzheimer's disease, and if they remove clumps of protein (amyloid plaque) in the brain in participants with Alzheimer's Disease. Participants will enroll into either A1D-MC-AT01 or A1D-MC-AT02 (upcoming).
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Amyloid
Plaque, Amy...